Charlie Kim

Charlie Kim is a mission-driven advisor to multiple startups, venture capital firms, and philanthropic organizations that are building datasets and tools for life science R&D. His technical expertise is in translational research, biomarker discovery, multi-omics, pathology, diagnostics, and AI.

Before starting his consulting business, Charlie built and directed the Molecular Science program at Verily, including general management of business lines in immunogenomics, proteomics, and pathology. Prior to this, he was a tenure-track faculty member in the Department of Medicine at the University of California, San Francisco.

Charlie earned his Ph.D. from the Department of Microbiology and Immunology at the Stanford University School of Medicine.

‍